| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8284122 | Maturitas | 2016 | 8 Pages |
Abstract
The evidence suggests that levels of IGF-1 and IGFBP-3 are lower in patients with ovarian cancer. In contrast, higher levels of IGBP-2 and IGBP-1 are found in patients with ovarian cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Ximena Gianuzzi, Gabriela Palma-Ardiles, Wendy Hernandez-Fernandez, Vinay Pasupuleti, Adrian V. Hernandez, Faustino R. Perez-Lopez,